Cheryl A. Thompson
BETHESDA, MD 28 January 2013—Injectable drug maker Hospira Inc. on January 25 announced the recall of lot 05-019-JT of lactated Ringer's and 5% dextrose injection because a customer found a particulate consistent with mold in one of the 1000-mL flexible containers.
The company said the bags in this lot had been distributed between June 2011 and January 2012 to wholesalers, hospitals, and pharmacies across the country.
Anyone with a bag of lactated Ringer's and 5% dextrose injection from lot 05-019-JT is being instructed to quarantine it immediately and call Stericycle at 888-965-5798 between 8 a.m. and 5 p.m. EST, Monday through Friday, to arrange for the return of the product.
Hospira said it is working to determine the root cause of the sterility problem.
As of Friday, the company had not identified any quality-related issues in its samples from lot 05-019-JT.
The company said replacement product from other lots is available.
For questions, comments, or
more information on this
article, please contact the
ASHP News Center at email@example.com.
Stay connected with ASHP through our social media tools.
What We Do
For the Press
Jobs at ASHP
AHFS Drug Information
Customer Service: 1-866-279-0681
8:00am - 6:00pm ET, Mon-Fri
American Society of Health-System Pharmacists. All rights reserved. 7272 Wisconsin Avenue, Bethesda, MD 20814